PRESS RELEASE

Q2 2021 — Press release

Q2 2021PDF · 13 pages335 KB
Page 1 of 6
N E W S 	R E L E A S E
(For Immediate Release)
UNITEDHEALTH GROUP REPORTS SECOND QUARTER 2021 RESULTS
• 	Revenues of $71.3 Billion Grew 15%, with Well-Diversified Growth at Optum and UnitedHealthcare
• 	Earnings from Operations were $6.0 Billion
• 	Cash Flows from Operations reached $5.5 Billion or 1.3x Net Income
• 	Net Earnings were $4.46 Per Share and Adjusted Earnings were $4.70 Per Share
MINNETONKA, Minn. (July 15, 2021) – Strong and diversified growth continued across UnitedHealth Group (NYSE:
UNH) in the second quarter 2021.
“The compassion, dedication and ongoing efforts of our 330,000 colleagues to advance peoples’ health and health
system performance reinforces our confidence in delivering strongly on our strategies for those we serve and continuing
to grow well into the future,” said Andrew Witty, chief executive officer of UnitedHealth Group.
Based upon first half 2021 performance, the Company increased its full year net earnings outlook to $17.35 to $17.85
per share and adjusted earnings to $18.30 to $18.80 per share. The outlook continues to include approximately $1.80 per
share in potential net unfavorable COVID-19 effects. UnitedHealth Group is focused on helping people access the care
they need, including vaccinations, and expects a continued rise in provision of care in the second half of this year.
COVID-19 effects include testing and treatment costs; the residual impact of people having deferred care in 2020; and
unemployment and other economy-driven factors.

-- 1 of 13 --

Page 2 of 6
Quarterly Financial Performance
Three Months Ended
June 30,
2021
June 30,
2020
March 31,
2021
Revenues 	$71.3 billion 	$62.1 billion 	$70.2 billion
Earnings from Operations 	$6.0 billion 	$9.2 billion 	$6.7 billion
Net Margin 	6.0% 	10.7% 	6.9%
• 	UnitedHealth Group’s second quarter 2021 revenues of $71.3 billion grew 14.8% year-over-year, reflecting
well-diversified growth across the enterprise, including double-digit percentage growth at both Optum and
UnitedHealthcare.
• 	Earnings from operations in the second quarter 2021 were $6.0 billion and adjusted earnings were $4.70 per
share, with the year-over-year comparisons reflecting the broad-based deferral of care during the second quarter
2020 due to the pandemic.
• 	Cash flows from operations in second quarter 2021 were $5.5 billion, or 1.3 times net income.
• 	The second quarter 2021 medical care ratio of 82.8% compared to 70.2% last year, with the variance due to
second quarter 2020 COVID-19 effects. Favorable medical reserve development was $500 million in the
quarter compared to $1.0 billion in the first quarter 2021 and $1.4 billion in the second quarter last year. Days
claims payable of 49.1 days compared to 49.8 days in the first quarter 2021 and 50.4 days in the second quarter
2020.
• 	The second quarter 2021 operating cost ratio of 14.5% decreased from 16.1% in second quarter 2020. Factors
contributing to the decline include the repeal of the health insurance tax, broad-based 2020 investments to
support people and health systems, the revenue-related effects of the pandemic, and continued productivity
advances, partially offset by business mix and investments.
• 	The Company returned $1.4 billion to shareholders in the second quarter via dividends, following a 16%
increase in June 2021. In the quarter, 3.2 million shares were repurchased for $1.2 billion, bringing year-to-date
repurchases to 7.9 million shares for $2.9 billion.
• 	Return on equity of 25.2% in the quarter reflected the Company’s strong and diverse earnings profile and
efficient capital base. Debt to total capital was 40.1% at quarter end.

-- 2 of 13 --

Page 3 of 6
UnitedHealthcare provides health care benefits globally, serving individuals and employers, and Medicare and Medicaid
beneficiaries. UnitedHealthcare is dedicated to improving the value customers and consumers receive by reducing the
total cost of care, enhancing the quality of care received, improving health and wellness and simplifying the health care
experience.
Quarterly Financial Performance
Three Months Ended
June 30,
2021
June 30,
2020
March 31,
2021
Revenues 	$55.5 billion 	$49.1 billion 	$55.1 billion
Earnings from Operations 	$3.1 billion 	$7.0 billion 	$4.1 billion
Operating Margin 	5.6% 	14.3% 	7.5%
• 	UnitedHealthcare second quarter 2021 revenues grew by $6.4 billion or 13.0% to $55.5 billion compared to
last year.
• 	Strong growth in UnitedHealthcare’s community and senior offerings resulted from expansion in people
served. Since the end of 2020, total people served by UnitedHealthcare grew by nearly 1.2 million, including
150,000 in the second quarter 2021.
• 	Second quarter 2021 operating earnings were $3.1 billion compared to $7.0 billion last year, reflecting strong
revenue growth, more than offset by pandemic driven deferral of care last year.
• 	Growth highlights include: continued strong membership growth during the first half this year in individual
Medicare Advantage, Group Medicare Advantage and Dual Special Needs Plans; Medicaid contract awards in
Hawaii and Ohio, as well as a strong pipeline of potential new and renewing awards during the remainder of
2021; and further expansion of innovative commercial benefit products and capabilities such as our care
provider-aligned and consumer-centric products, and continued outlook for strong specialty benefits growth.

-- 3 of 13 --

Page 4 of 6
Optum is a health services business serving the global health care marketplace, including payers, care providers,
employers, governments, life sciences companies and consumers. Using market-leading information, data analytics,
technology and clinical insights, Optum helps improve overall health system performance: optimizing care quality,
reducing health care costs and improving the consumer experience.
Quarterly Financial Performance
Three Months Ended
June 30,
2021
June 30,
2020
March 31,
2021
Revenues 	$38.3 billion 	$32.7 billion 	$36.4 billion
Earnings from Operations 	$2.9 billion 	$2.2 billion 	$2.6 billion
Operating Margin 	7.5% 	6.8% 	7.2%
• 	Optum second quarter revenues of $38.3 billion grew 17.2% and operating earnings of $2.9 billion grew
29.1%, with each of the three Optum businesses contributing double-digit operating earnings growth.
• 	OptumHealth served 99 million people at the end of second quarter 2021 compared to 97 million a year ago,
and revenue per consumer served increased 43% year-over-year. This continues the expansion of people served
in value-based care arrangements, growth in affiliated physicians and build-out of local market care delivery
services including in-home, clinic-based and outpatient services, all on a multi-payer basis.
• 	OptumInsight’s revenue backlog increased by $1.9 billion or 10% compared to the second quarter 2020 to
$21.3 billion, driven by growth in comprehensive managed services. OptumInsight continues to advance
initiatives to help health systems scale essential capabilities through the deployment of advanced technology,
innovative talent and labor models and progressive approaches to productivity enhancements. This includes a
significant new client relationship with Bassett Healthcare Network to help them improve clinical and
operational performance.
• 	OptumRx adjusted scripts in the quarter were 342 million, growth of 8% compared to last year and 4% from
the first quarter 2021, as the provision of care has continued to recover over the last year.
• 	Growth highlights include: continued expansion of Optum Care’s integrated care delivery networks and growth
serving people in their homes; OptumInsight new business wins and continued pipeline expansion in
comprehensive managed services, including revenue management, information technology, data analytics and
payment integrity; and OptumRx’s continued diversification and growth of pharmacy care services, highlighted
by specialty pharmacy, infusion services, community-based behavioral health pharmacies and e-commerce.

-- 4 of 13 --

Page 5 of 6
About UnitedHealth Group
UnitedHealth Group (NYSE: UNH) is a diversified health care company dedicated to helping people live healthier lives
and helping make the health system work better for everyone. UnitedHealth Group offers a broad spectrum of products
and services through two distinct platforms: Optum, which provides information and technology-enabled health
services; and UnitedHealthcare, which provides health care coverage and benefits services. For more information, visit
UnitedHealth Group at www.unitedhealthgroup.com or follow @UnitedHealthGrp on Twitter.
Earnings Conference Call
As previously announced, UnitedHealth Group will discuss the company’s results, strategy and future outlook on a
conference call with investors at 8:45 a.m. Eastern Time today. UnitedHealth Group will host a live webcast of this
conference call from the Investor Relations page of the company’s website (www.unitedhealthgroup.com). Following
the call, a webcast replay will be available on the same site through July 29, 2021. The conference call replay can also
be accessed by dialing 1-888-203-1112, Conference Code: 6765563. This earnings release and the Form 8-K dated
July 15, 2021 can also be accessed from the Investor Relations page of the Company’s website.
Non-GAAP Financial Information
This news release presents non-GAAP financial information provided as a complement to the results provided in
accordance with accounting principles generally accepted in the United States of America (“GAAP”). A reconciliation
of the non-GAAP financial information to the most directly comparable GAAP financial measure is provided in the
accompanying tables found at the end of this release.
Forward-Looking Statements
The statements, estimates, projections, guidance or outlook contained in this document include “forward-looking”
statements which are intended to take advantage of the “safe harbor” provisions of the federal securities law. The words
“believe,” “expect,” “intend,” “estimate,” “anticipate,” “forecast,” “outlook,” “plan,” “project,” “should” and similar
expressions identify forward-looking statements. These statements may contain information about financial prospects,
economic conditions and trends and involve risks and uncertainties. Actual results could differ materially from those that
management expects, depending on the outcome of certain factors including: risks associated with public health crises,
large-scale medical emergencies and pandemics, such as the COVID-19 pandemic; our ability to effectively estimate,
price for and manage medical costs; new or changes in existing health care laws or regulations, or their enforcement or
application; the DOJ’s legal action relating to the risk adjustment submission matter; our ability to maintain and achieve
improvement in quality scores impacting revenue; reductions in revenue or delays to cash flows received under
government programs; changes in Medicare, the CMS star ratings program or the application of risk adjustment data
validation audits; failure to maintain effective and efficient information systems or if our technology products do not
operate as intended; cyberattacks, other privacy/data security incidents, or our failure to comply with related regulations;
risks and uncertainties associated with the pharmacy benefits management industry; competitive pressures; changes in or
challenges to our public sector contract awards; our ability to contract on competitive terms with physicians, hospitals
and other service providers; failure to attract, develop, retain, and manage the succession of key employees and

-- 5 of 13 --

Page 6 of 6
executives; the impact of potential changes in tax laws and regulations (including any increase in the U.S. income tax
rate applicable to corporations); failure to achieve targeted operating cost productivity improvements; increases in costs
and other liabilities associated with litigation, government investigations, audits or reviews; failure to manage
successfully our strategic alliances or complete or receive anticipated benefits of strategic transactions; fluctuations in
foreign currency exchange rates; downgrades in our credit ratings; our investment portfolio performance; impairment of
our goodwill and intangible assets; and our ability to obtain sufficient funds from our regulated subsidiaries or from
external financings to fund our obligations, maintain our debt to total capital ratio at targeted levels, maintain our
quarterly dividend payment cycle, or continue repurchasing shares of our common stock. This above list is not
exhaustive. We discuss these matters, and certain risks that may affect our business operations, financial condition and
results of operations more fully in our filings with the SEC, including our reports on Forms 10-K, 10-Q and 8-K. By
their nature, forward-looking statements are not guarantees of future performance or results and are subject to risks,
uncertainties and assumptions that are difficult to predict or quantify. Actual results may vary materially from
expectations expressed or implied in this document or any of our prior communications. You should not place undue
reliance on forward-looking statements, which speak only as of the date they are made. We do not undertake to update or
revise any forward-looking statements, except as required by law.
# # #
Investors: 	Brett Manderfeld 	Media: 	Matt Stearns
Senior Vice President 	Senior Vice President
952-936-7216 	202-276-0085

-- 6 of 13 --

UNITEDHEALTH GROUP
Earnings Release Schedules and Supplementary Information
Quarter Ended June 30, 2021
• Condensed Consolidated Statements of Operations
• Condensed Consolidated Balance Sheets
• Condensed Consolidated Statements of Cash Flows
• Supplemental Financial Information - Businesses
• Supplemental Financial Information - Business Metrics
• Reconciliation of Non-GAAP Financial Measure

-- 7 of 13 --

UNITEDHEALTH GROUP
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in millions, except per share data)
(unaudited)
Three Months Ended
June 30, Six Months Ended
June 30,
2021 2020 2021 2020
Revenues
Premiums............................................................................................................................ $56,233 $49,394 $111,719 $100,034
Products.............................................................................................................................. 8,433 8,247 16,773 16,678
Services.............................................................................................................................. 6,099 4,156 12,017 9,141
Investment and other income.............................................................................................. 556 341 1,008 706
Total revenues................................................................................................................ 71,321 62,138 141,517 126,559
Operating costs
Medical costs...................................................................................................................... 46,546 34,678 91,450 75,678
Operating costs................................................................................................................... 10,359 10,001 20,582 20,016
Cost of products sold.......................................................................................................... 7,660 7,501 15,232 15,188
Depreciation and amortization............................................................................................ 778 717 1,536 1,440
Total operating costs...................................................................................................... 65,343 52,897 128,800 112,322
Earnings from operations................................................................................................ 5,978 9,241 12,717 14,237
Interest expense.................................................................................................................. (410) (430) (807) (867)
Earnings before income taxes......................................................................................... 5,568 8,811 11,910 13,370
Provision for income taxes.................................................................................................. (1,196) (2,115) (2,560) (3,209)
Net earnings ..................................................................................................................... 4,372 6,696 9,350 10,161
Earnings attributable to noncontrolling interests................................................................. (106) (59) (222) (142)
Net earnings attributable to UnitedHealth Group common shareholders................... $4,266 $6,637 $9,128 $10,019
Diluted earnings per share attributable to UnitedHealth Group common
shareholders ................................................................................................................. $4.46 $6.91 $9.55 $10.43
Adjusted earnings per share attributable to UnitedHealth Group common
shareholders (a)............................................................................................................. $4.70 $7.12 $10.02 $10.84
Diluted weighted-average common shares outstanding..................................................... 956 960 956 961
(a) See page 6 for a reconciliation of the non-GAAP measure
1

-- 8 of 13 --

UNITEDHEALTH GROUP
CONDENSED CONSOLIDATED BALANCE SHEETS
(in millions)
(unaudited)
June 30,
2021 December 31,
2020
Assets
Cash and short-term investments..................................................................................................................... $22,561 $19,781
Accounts receivable, net................................................................................................................................... 14,587 12,870
Other current assets.......................................................................................................................................... 21,768 21,067
Total current assets.................................................................................................................................. 58,916 53,718
Long-term investments...................................................................................................................................... 44,061 41,242
Other long-term assets...................................................................................................................................... 107,315 102,329
Total assets................................................................................................................................................. $210,292 $197,289
Liabilities, redeemable noncontrolling interests and equity
Medical costs payable....................................................................................................................................... $25,131 $21,872
Short-term borrowings and current maturities of long-term debt....................................................................... 3,868 4,819
Other current liabilities....................................................................................................................................... 47,558 45,729
Total current liabilities............................................................................................................................... 76,557 72,420
Long-term debt, less current maturities............................................................................................................. 44,348 38,648
Other long-term liabilities................................................................................................................................... 16,066 15,682
Redeemable noncontrolling interests................................................................................................................ 1,299 2,211
Equity................................................................................................................................................................ 72,022 68,328
Total liabilities, redeemable noncontrolling interests and equity.................................................................. $210,292 $197,289
2

-- 9 of 13 --

UNITEDHEALTH GROUP
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in millions)
(unaudited)
Six Months Ended
June 30,
2021 2020
Operating Activities
Net earnings....................................................................................................................................................................... $9,350 $10,161
Noncash items:
Depreciation and amortization........................................................................................................................................ 1,536 1,440
Deferred income taxes and other.................................................................................................................................... 113 238
Share-based compensation............................................................................................................................................ 426 388
Net changes in operating assets and liabilities.................................................................................................................. 120 719
Cash flows from operating activities............................................................................................................................ 11,545 12,946
Investing Activities
(Purchases of investments, net of sales and maturities) Sales and maturities, net of purchases..................................... (2,789) 573
Purchases of property, equipment and capitalized software.............................................................................................. (1,130) (920)
Cash paid for acquisitions, net........................................................................................................................................... (4,642) (3,952)
Other, net............................................................................................................................................................................ (648) (186)
Cash flows used for investing activities....................................................................................................................... (9,209) (4,485)
Financing Activities
Common share repurchases.............................................................................................................................................. (2,900) (1,691)
Dividends paid.................................................................................................................................................................... (2,548) (2,212)
Net change in short-term borrowings and long-term debt.................................................................................................. 4,858 5,215
Other, net............................................................................................................................................................................ 1,159 1,712
Cash flows from financing activities............................................................................................................................. 569 3,024
Effect of exchange rate changes on cash and cash equivalents....................................................................................... 6 (143)
Increase in cash and cash equivalents.............................................................................................................................. 2,911 11,342
Cash and cash equivalents, beginning of period................................................................................................................ 16,921 10,985
Cash and cash equivalents, end of period......................................................................................................................... $19,832 $22,327
3

-- 10 of 13 --

UNITEDHEALTH GROUP
SUPPLEMENTAL FINANCIAL INFORMATION - BUSINESSES
(in millions, except percentages)
(unaudited)
Three Months Ended
June 30, Six Months Ended
June 30,
2021 2020 2021 2020
Revenues
UnitedHealthcare.................................................................................................................. $55,474 $49,107 $110,588 $100,175
Optum................................................................................................................................... 38,303 32,695 74,687 65,534
Eliminations.......................................................................................................................... (22,456) (19,664) (43,758) (39,150)
Total consolidated revenues.......................................................................................... $71,321 $62,138 $141,517 $126,559
Earnings from Operations
UnitedHealthcare.................................................................................................................. $3,095 $7,007 $7,203 $9,895
Optum (a)............................................................................................................................. 2,883 2,234 5,514 4,342
Total consolidated earnings from operations................................................................. $5,978 $9,241 $12,717 $14,237
Operating Margin
UnitedHealthcare.................................................................................................................. 5.6% 14.3% 6.5% 9.9%
Optum................................................................................................................................... 7.5% 6.8% 7.4% 6.6%
Consolidated operating margin...................................................................................... 8.4% 14.9% 9.0% 11.2%
Revenues
UnitedHealthcare Employer & Individual.............................................................................. $14,942 $12,963 $29,574 $27,243
UnitedHealthcare Medicare & Retirement............................................................................ 25,304 22,855 50,778 46,007
UnitedHealthcare Community & State.................................................................................. 13,110 11,523 26,083 22,976
UnitedHealthcare Global...................................................................................................... 2,118 1,766 4,153 3,949
OptumHealth........................................................................................................................ $13,300 $9,139 $25,703 $18,331
OptumInsight........................................................................................................................ 2,957 2,632 5,809 5,126
OptumRx.............................................................................................................................. 22,524 21,371 44,128 42,928
Optum eliminations............................................................................................................... (478) (447) (953) (851)
(a) Earnings from operations for Optum for the three and six months ended June 30, 2021 included $1,128 and $2,090 for OptumHealth; $762 and $1,541 for
OptumInsight; and $993 and $1,883 for OptumRx, respectively. Earnings from operations for Optum for the three and six months ended June 30, 2020 included $841
and $1,553 for OptumHealth; $561 and $1,097 for OptumInsight; and $832 and $1,692 for OptumRx, respectively.
4

-- 11 of 13 --

UNITEDHEALTH GROUP
SUPPLEMENTAL FINANCIAL INFORMATION - BUSINESS METRICS
UNITEDHEALTHCARE CUSTOMER PROFILE
(in thousands)
People Served June 30, 2021 March 31, 2021 December 31, 2020 June 30, 2020
Commercial:
Risk-based........................................................................ 7,840 7,860 7,910 8,065
Fee-based......................................................................... 18,395 18,455 18,310 18,705
Total Commercial............................................................ 26,235 26,315 26,220 26,770
Medicare Advantage............................................................. 6,385 6,335 5,710 5,605
Medicaid................................................................................ 7,130 6,975 6,620 6,210
Medicare Supplement (Standardized).................................. 4,390 4,390 4,460 4,450
Total Community and Senior........................................ 17,905 17,700 16,790 16,265
Total UnitedHealthcare - Domestic Medical................ 44,140 44,015 43,010 43,035
Global.................................................................................... 5,485 5,460 5,425 5,365
Total UnitedHealthcare - Medical.................................. 49,625 49,475 48,435 48,400
Supplemental Data
Medicare Part D stand-alone........................................... 3,750 3,795 4,045 4,120
OPTUM PERFORMANCE METRICS
June 30, 2021 March 31, 2021 December 31, 2020 June 30, 2020
OptumHealth Consumers Served (in millions)........................ 99 99 98 97
OptumInsight Contract Backlog (in billions)............................ $21.3 $20.8 $20.2 $19.4
OptumRx Quarterly Adjusted Scripts (in millions)................... 342 329 331 316
Note: UnitedHealth Group served 146 million unique individuals across all businesses at June 30, 2021.
5

-- 12 of 13 --

UNITEDHEALTH GROUP
RECONCILIATION OF NON-GAAP FINANCIAL MEASURE
(in millions, except per share data)
(unaudited)
ADJUSTED NET EARNINGS PER SHARE(a)
Three Months Ended
June 30, Six Months Ended
June 30,
Projected
Year Ended
December 31,
2021 2020 2021 2020 2021
GAAP net earnings attributable to UnitedHealth Group common shareholders............. $4,266 $6,637 $9,128 $10,019 $16,550 - $17,050
Intangible amortization.................................................................................................... 305 267 599 532 ~1,190
Tax effect of intangible amortization................................................................................ (75) (65) (146) (130) ~(290)
Adjusted net earnings attributable to UnitedHealth Group common shareholders... $4,496 $6,839 $9,581 $10,421 $17,450 - $17,950
GAAP diluted earnings per share.................................................................................... $4.46 $6.91 $9.55 $10.43 $17.35 - $17.85
Intangible amortization per share.................................................................................... 0.32 0.28 0.63 0.55 ~1.25
Tax effect per share of intangible amortization................................................................ (0.08) (0.07) (0.16) (0.14) ~(0.30)
Adjusted diluted earnings per share......................................................................... $4.70 $7.12 $10.02 $10.84 $18.30 - $18.80
(a) Adjusted net earnings per share is a non-GAAP financial measure. Non-GAAP financial measures should be considered in addition to, but not as a substitute for, or
superior to, financial measures prepared in accordance with GAAP.
Adjusted net earnings per share excludes from the relevant GAAP metric, as applicable, intangible amortization and other items, if any, that do not relate to the
Company's underlying business performance. Management believes that the use of adjusted net earnings per share provides investors and management useful
information about the earnings impact of acquisition-related intangible asset amortization. As amortization fluctuates based on the size and timing of the Company’s
acquisition activity, management believes this exclusion provides a more useful comparison of the Company's underlying business performance and trends from
period to period. While intangible assets contribute to the Company’s revenue generation, the intangible amortization is not directly related. Therefore, the related
revenues are included in adjusted earnings per share.
6

-- 13 of 13 --